LU88801I2 - Mélange des stéréoisomères (1R, 1'R,2S,2'S),(1R,1'R,2S,2'R)et(1R,1'R,2R,2'R)(des isomères trans-trans trans-cis et cis-cis respectivement)du(E)-1,1',2,2',3,3',4,4'-octahydro-6,6',7,7'-tétraméthoxy-2,2'-diméthyl-1,1'-bis(3,4,5-triméthoxybenzyl)-2,2'-[oct-4-ènedioylbis-(oxytriméthylène)] di-isoquinoléine*2X , où X est un anion pharmaceutiquement acceptable y compris le chlorure - Google Patents

Mélange des stéréoisomères (1R, 1'R,2S,2'S),(1R,1'R,2S,2'R)et(1R,1'R,2R,2'R)(des isomères trans-trans trans-cis et cis-cis respectivement)du(E)-1,1',2,2',3,3',4,4'-octahydro-6,6',7,7'-tétraméthoxy-2,2'-diméthyl-1,1'-bis(3,4,5-triméthoxybenzyl)-2,2'-[oct-4-ènedioylbis-(oxytriméthylène)] di-isoquinoléine*2X , où X est un anion pharmaceutiquement acceptable y compris le chlorure

Info

Publication number
LU88801I2
LU88801I2 LU88801C LU88801C LU88801I2 LU 88801 I2 LU88801 I2 LU 88801I2 LU 88801 C LU88801 C LU 88801C LU 88801 C LU88801 C LU 88801C LU 88801 I2 LU88801 I2 LU 88801I2
Authority
LU
Luxembourg
Prior art keywords
cis
trans
pharmaceutically acceptable
enedioylbis
oxytrimethylene
Prior art date
Application number
LU88801C
Other languages
English (en)
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of LU88801I2 publication Critical patent/LU88801I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Jib Cranes (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
  • Cephalosporin Compounds (AREA)
LU88801C 1984-07-18 1985-07-17 Mélange des stéréoisomères (1R, 1'R,2S,2'S),(1R,1'R,2S,2'R)et(1R,1'R,2R,2'R)(des isomères trans-trans trans-cis et cis-cis respectivement)du(E)-1,1',2,2',3,3',4,4'-octahydro-6,6',7,7'-tétraméthoxy-2,2'-diméthyl-1,1'-bis(3,4,5-triméthoxybenzyl)-2,2'-[oct-4-ènedioylbis-(oxytriméthylène)] di-isoquinoléine*2X , où X est un anion pharmaceutiquement acceptable y compris le chlorure LU88801I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
LU88801I2 true LU88801I2 (fr) 1996-11-05

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88801C LU88801I2 (fr) 1984-07-18 1985-07-17 Mélange des stéréoisomères (1R, 1'R,2S,2'S),(1R,1'R,2S,2'R)et(1R,1'R,2R,2'R)(des isomères trans-trans trans-cis et cis-cis respectivement)du(E)-1,1',2,2',3,3',4,4'-octahydro-6,6',7,7'-tétraméthoxy-2,2'-diméthyl-1,1'-bis(3,4,5-triméthoxybenzyl)-2,2'-[oct-4-ènedioylbis-(oxytriméthylène)] di-isoquinoléine*2X , où X est un anion pharmaceutiquement acceptable y compris le chlorure

Country Status (30)

Country Link
US (1) US4761418A (fr)
EP (1) EP0181055B1 (fr)
JP (1) JPH0662568B2 (fr)
AT (1) ATE60759T1 (fr)
AU (1) AU574481B2 (fr)
BG (1) BG60411B2 (fr)
CA (1) CA1273341A (fr)
CY (1) CY1687A (fr)
DD (1) DD235638A5 (fr)
DE (2) DE19675039I2 (fr)
DK (1) DK168093B1 (fr)
ES (1) ES8609260A1 (fr)
FI (1) FI85019C (fr)
GB (1) GB8418303D0 (fr)
GE (1) GEP19960468B (fr)
HK (1) HK47593A (fr)
HU (1) HU193996B (fr)
IE (1) IE58138B1 (fr)
IL (1) IL75833A (fr)
LT (1) LT2078B (fr)
LU (1) LU88801I2 (fr)
LV (1) LV5483A3 (fr)
MC (1) MC1690A1 (fr)
MX (1) MX9203667A (fr)
NL (1) NL940023I2 (fr)
NZ (1) NZ212766A (fr)
PL (1) PL146066B1 (fr)
SG (1) SG3493G (fr)
SU (1) SU1468414A3 (fr)
ZA (1) ZA855407B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类，其制备方法，药物组合物及其制药用途
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
WO2005041960A2 (fr) * 2003-10-28 2005-05-12 Cornell Research Foundation, Inc. Agents de blocage neuromusculaires et leurs antagonistes
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
AU2008222298A1 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
EP2125743A1 (fr) * 2007-03-26 2009-12-02 Chemagis Ltd. Procédé de séparation de sels de (1r, 1'r)-atracurium
US8293912B2 (en) * 2007-05-01 2012-10-23 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
CA2685488A1 (fr) * 2007-05-01 2008-11-06 Chemagis Ltd. Nouveaux composes d'isoquinolinium utiles dans la preparation de cisatracurium et intermediaires associes
CA2687157A1 (fr) * 2007-06-18 2008-12-24 Chemagis Ltd. Procede de separation de sels de (1r,1'r)-atracurium
BRPI0812625A2 (pt) * 2007-07-09 2019-02-19 Chemagis Ltd processo para preparar um sal de cis-atracúrio
CA2702535A1 (fr) * 2007-10-29 2009-05-07 Chemagis Ltd. Nouveaux sels de r,r'-atracurium
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
CA2722651A1 (fr) * 2008-05-01 2009-11-05 Chemagis Ltd. Derives de cisatracurium, preparation et utilisations de ceux-ci
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2013021398A2 (fr) * 2011-08-05 2013-02-14 Sequent Scientific Limited Procédé de préparation du chlorure de mivacurium
JP6236077B2 (ja) * 2012-06-29 2017-11-22 コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法
CN116410078B (zh) * 2021-12-29 2026-04-03 苏州特瑞药业股份有限公司 一种制备(e)-辛-4-烯-1,8-二酸的方法
WO2025140288A1 (fr) * 2023-12-25 2025-07-03 上海森辉医药有限公司 Tétrahydroisoquinoléine et son utilisation pharmaceutique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
NL7808067A (nl) 1977-08-01 1979-02-05 Massachusetts Gen Hospital Werkwijze voor het bereiden van een middel dat zenuw- spieren blokkeert.
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (fr) * 1978-07-21 1982-06-08 John J. Savarese Modes d'emploi de substances a base de bis-isoquinolinium
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1153380A (fr) 1979-10-19 1983-09-06 Hassan A. El-Sayad Sels de tetrahydroisoquinolinium, agents de blocage neuromusculaire
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
EP0054309B1 (fr) * 1980-12-17 1984-08-22 The Wellcome Foundation Limited Bloqueurs neuromusculaires à action prolongée, compositions pharmaceutiques les contenant et leurs procédés de préparation
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
FI852807A0 (fi) 1985-07-17
IE851791L (en) 1986-01-18
FI85019B (fi) 1991-11-15
IE58138B1 (en) 1993-07-14
AU4510885A (en) 1986-01-23
GEP19960468B (en) 1996-08-29
EP0181055A1 (fr) 1986-05-14
DK168093B1 (da) 1994-02-07
MC1690A1 (fr) 1986-07-18
HUT40626A (en) 1987-01-28
PL146066B1 (en) 1988-12-31
JPH0662568B2 (ja) 1994-08-17
MX9203667A (es) 1992-07-31
HK47593A (en) 1993-05-21
US4761418A (en) 1988-08-02
DK324985D0 (da) 1985-07-17
LT2078B (lt) 1993-06-15
CY1687A (en) 1993-10-10
DD235638A5 (de) 1986-05-14
NZ212766A (en) 1988-03-30
EP0181055B1 (fr) 1991-02-06
CA1273341A (fr) 1990-08-28
PL254571A1 (en) 1986-07-15
GB8418303D0 (en) 1984-08-22
NL940023I1 (nl) 1995-01-02
DE19675039I2 (de) 2003-01-09
IL75833A0 (en) 1985-11-29
DK324985A (da) 1986-01-19
AU574481B2 (en) 1988-07-07
ZA855407B (en) 1986-04-30
ATE60759T1 (de) 1991-02-15
DE3581699D1 (de) 1991-03-14
SU1468414A3 (ru) 1989-03-23
SG3493G (en) 1993-03-12
LV5483A3 (lv) 1994-03-10
FI852807L (fi) 1986-01-19
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
ES8609260A1 (es) 1986-09-01
HU193996B (en) 1987-12-28
BG60411B2 (bg) 1995-02-28
JPS6187666A (ja) 1986-05-06
FI85019C (fi) 1992-02-25
NL940023I2 (nl) 1998-06-02

Similar Documents

Publication Publication Date Title
ES545319A0 (es) Un procedimiento para preparar derivados de trimetoxibencil-isoquinolinio
AU541976B2 (en) Isoquinoline derivatives
ES507414A0 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
ES2140765T3 (es) Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene.
ES480560A1 (es) Un procedimiento para la preparacion de un vincaderivado di-mero puenteado.
KR930700533A (ko) 교원효소 억제활성을 갖는 포스포노펩티드
MY108501A (en) Novel antiarrhythmic agents ii.
MY106222A (en) Azole-1-alkanamides as antiarrhythmic agents and preparation thereof.
JO1594B1 (en) New factors against a heart rhythm disorder
SE8303862L (sv) Ny forening 2-(hexahydroazepin)-n-(2,6-dimetylfenyl)acetamid, klorvetet av denna forening, forfarande for framstellning av foreningen samt farmaceutiska sammansettningar innehallande foreningarna
JO1618B1 (en) New Factors # 2 against a heart rhythm disorder